HealthPhase 3 Trial Finds Longer Median Survival With DivarasibBy Naomi CalderOct 25, 2026, 8:51 PM UTC
HealthTests Show Pope Leo’s Lung Cancer Was Localized After SurgeryBy Naomi CalderOct 22, 2026, 5:03 AM UTC
HealthOSE Reports 47% One-Year Survival With Tedopi in Lung Cancer TrialBy Naomi CalderOct 19, 2026, 8:33 AM UTC
HealthPope Leo Plans Gradual Return as Doctors Await Tumor Test ResultsBy Naomi CalderOct 18, 2026, 11:33 AM UTC
